期刊
PEDIATRIC RESEARCH
卷 65, 期 5, 页码 64R-70R出版社
NATURE PUBLISHING GROUP
DOI: 10.1203/PDR.0b013e3181a0977e
关键词
-
类别
资金
- NIAID/NIH
- Doris Duke Charitable Foundation
- Pfizer
One of the greatest obstacles to the control of malaria has been the spread of resistance to drugs used on a large scale. This review provides an update of the current understanding of the molecular basis for antimalarial drug resistance. Parasite intrinsic resistance is just one component that determines the in vivo efficacy of a drug. Human immune responses and pharmacologic properties play important roles in determining the clinical outcome of treatment. The emergence and spread of resistance also results' from an interplay of these factors. Current efforts to characterize and deter resistance to new combination therapy are also discussed. (Pediatr Res 65: 64R-70R, 2009)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据